Understanding Pharmacovigilance Regulations in APAC Training Course

Pharmacovigilance Manager at Accestra Consulting

Mr. Raphael Tian is a seasoned pharmacovigilance Manager at Accestra Consulting, with extensive experience in top global pharmaceutical companies and a focus on the Chinese market. With hands-on experience in Adverse Event monitoring and reporting, Literature screening, Research Related Programs, Market Research and Patient Support Programs, PV agreements, Chinese GVP, and local regulations. Raphael is an experienced trainer in pharmacovigilance with a strong communication network in the local and global pharmaceutical industry in China. To learn more about Raphael or Accestra Consulting, please visit www.accestra.com.

RA & PV Director at Accestra Consulting 

Ms. Ye has been dedicated to regulatory affairs consulting for 15 years with a Pharmacy degree from Zhejiang University, China. 

She is experienced in regulatory compliance of China market access & post-marketing maintenance of pharmaceutical products, providing insightful and customised solutions to international pharmaceutical companies and government institutions. 

She leads the registration team to plan, develop and implement compliance strategies for top pharma clients and has a successful track record for obtaining market approval for drug products, APIs, Excipients, Packaging Materials, medical devices and other products.

Ms. Ye has a strong communication network with Chinese authorities (e.g. NMPA and CDE) and industry experts in China. 

To learn more about Helen or Accestra Consulting, please visit their website at www.accestra.com

Drug Safety Manager at Pharma To Market

Mr. Param Dayal is a qualified Microbiologist with Master’s degree in Microbiology and a certified MedDRA coder. For the last 15 years, Param has worked on a variety of pharmacovigilance projects with special focus on ICSR processing (Unsolicited, solicited, Literature, legal and Clinical trials cases). In his previous roles he worked for organisations supporting pharma clients with PSP program management, PV audits, HA inspections, data migration, SOP Management, process refinement, providing PV training and mentoring to new staff. He also has experience working as a QPPV and Local Safety Officer for Australia and New Zealand. He is currently based in Melbourne working as Drug Safety Manager for Pharma To Market, managing PV activities for NZ clients.

Ms. Siew Man Phang is a registered pharmacist in Malaysia, brings over 7 years of pharmacovigilance and regulatory expertise. She has served as QPPV for multinational pharmaceutical, generic, and distributor companies, gaining diverse experience across innovator drugs, generics, biologics, health supplements, traditional products, cosmetic and medical devices.

Additionally, she possesses extensive hands-on experience in pharmacovigilance, including adverse event monitoring & reporting, literature & regulatory Intelligence screening, risk management plan, SOP and PSMF writing. She is currently based in Malaysia, works as a Regulatory & Pharmacovigilance Assistant Manager in Pharma To Market handling various pharmaceutical clients, serving as QPPV and managing Pharmacovigilance activities in APAC regions.

Senior Regulatory Affairs Manager 

Ms. Wang is a senior regulatory affairs consultant specializing in the Chinese market with a Double Master’s Degree from Fudan University and Luiss Guido Carli University.

She has in-depth understanding on Chinese Pharmaceutical regulations and accumulated extensive hands-on experience with API DMF registration & regulatory consulting projects during daily work.

Ms. Wang has strong communication network with Chinese authorities including NMPA and CDE.

A successful track record with supporting international pharma with market entry into China including big and small pharma.

Dr. Preeti Shergill holds a PhD in Biotechnology and brings over 8 years of experience in Pharmacovigilance, having worked extensively in India as a Safety Specialist and PV Manager.

Currently serving as a Drug Safety Associate at Pharma To Market, Dr. Shergill applies deep scientific knowledge and regulatory expertise to ensure the safe and effective use of pharmaceutical products.

With a strong foundation in biotechnology and a proven track record in drug safety, she is committed to advancing global health through vigilant monitoring and risk management.

Ms. Nurin Qistina Roslan is a master’s degree graduate in biomedical science with over 5 years of experience in Pharmacovigilance activities for multinational drug companies. She has hands-on experience in Pharmacovigilance for multinational pharmaceutical, generic, innovator, and biologic products at both local and global levels.

Furthermore, Ms. Roslan possesses extensive experience in adverse event monitoring and reporting, literature and regulatory intelligence screening, PSMF writing, and risk management planning. She is currently based in Malaysia and worked as a Pharmacovigilance Consultant at Pharma To Market, handling various pharmaceutical clients, serving as a QPPV, and managing Pharmacovigilance activities in the APAC region.

Ms. Clarise Macalalad is a registered pharmacist in the Philippines with over 10 years of experience in Pharmacovigilance and Regulatory Affairs. She has served as a Qualified Person for Pharmacovigilance (QPPV) for pharmaceutical, generic, and distribution companies.

She brings extensive hands-on expertise in adverse event monitoring, regulatory intelligence, and risk management planning. Currently, she is based in the Philippines as a Regulatory Project Manager, handling a diverse portfolio of clients.